TD Asset Management
RVMD icon

TD Asset Management’s Revolution Medicines RVMD Stock Holding History

TD Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.2M Sell
156,077
-161,734
-51% -$23.6M 0.03% 419
2026
Q1 		$30.9M Sell
317,811
-52,709
-14% -$5.32M 0.03% 419
2025
Q4 		$29.5M Sell
370,520
-165,084
-31% -$10.8M 0.02% 427
2025
Q3 		$25M Buy
535,604
+28,004
+6% +$1.1M 0.02% 456
2025
Q2 		$18.7M Buy
507,600
+181,724
+56% +$6.98M 0.02% 506
2025
Q1 		$11.5M Buy
325,876
+44,490
+16% +$1.81M 0.01% 603
2024
Q4 		$12.3M Buy
281,386
+37,852
+16% +$1.91M 0.01% 608
2024
Q3 		$10.8M Sell
243,534
-6,660
-3% -$290K 0.01% 629
2024
Q2 		$9.71M Sell
250,194
-4,400
-2% -$164K 0.01% 624
2024
Q1 		$8.21M Sell
254,594
-17,166
-6% -$509K 0.01% 660
2023
Q4 		$7.79M Sell
271,760
-64
-0% -$1.54K 0.01% 659
2023
Q3 		$7.52M Buy
271,824
+140,012
+106% +$4.15M 0.01% 638
2023
Q2 		$3.53M Sell
131,812
-2,700
-2% -$66.2K ﹤0.01% 814
2023
Q1 		$2.91M Buy
134,512
+40,339
+43% +$993K ﹤0.01% 877
2022
Q4 		$2.24M Hold
94,173
– – ﹤0.01% 949
2022
Q3 		$1.84M Buy
94,173
+13,876
+17% +$305K ﹤0.01% 1024
2022
Q2 		$1.56M Sell
80,297
-8,103
-9% -$158K ﹤0.01% 1076
2022
Q1 		$2.25M Buy
88,400
+15,400
+21% +$335K ﹤0.01% 1051
2021
Q4 		$1.84M Hold
73,000
– – ﹤0.01% 1152
2021
Q3 		$2.01M Buy
73,000
+44,600
+157% +$1.3M ﹤0.01% 1082
2021
Q2 		$813K Buy
+28,400
New +$991K ﹤0.01% 1298
2020
Q3 		– Sell
-9,370
Closed -$296K – 1394
2020
Q2 		$296K Hold
9,370
– – ﹤0.01% 1266
2020
Q1 		$205K Buy
+9,370
New +$259K ﹤0.01% 1314

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

TD Asset Management's RVMD Position: Q2 2026 in Review

TD Asset Management reduced its Revolution Medicines (RVMD) stake by 51% in Q2 2026, selling an estimated $23.6M and leaving 156,077 shares worth $29.2M. The position accounts for 0.03% of the portfolio, ranked #419.

TD Asset Management first reported a position in RVMD in Q1 2020 and has held it in 23 quarters since. The position peaked at $30.9M in Q1 2026. 484 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • TD Asset Management held 156,077 shares of Revolution Medicines worth $29.2M as of Q2 2026.
  • TD Asset Management sold 161,734 Revolution Medicines shares in Q2 2026, an estimated $23.6M.
  • Revolution Medicines made up 0.03% of TD Asset Management's portfolio in Q2 2026, its #419 holding.
  • TD Asset Management first reported a position in Revolution Medicines in Q1 2020 and has held it in 23 quarters since.
  • TD Asset Management's Revolution Medicines position peaked at $30.9M in Q1 2026.
  • 484 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.